About Vernal
Vernal is a Healthcare company based in New York (United States) founded in 2010, and was acquired by Orioninc in March 2017. A fragment and structure-based drug discovery platform is provided. Its focus areas include HealthTech, Life Sciences Tech, Research & Development and Drug Discovery. Its competitors include NTxBio, Nimble Therapeutics and Applied BioMath; 3 of its 3 listed competitors have raised funding.
Company details
Vernalis was founded in 2010 and is headquartered in New York, United States. Operations focus on the biotechnology sector, where a specialized platform for fragment and structure-based drug discovery is utilized. Services encompass early-stage research tools and methodologies to support pharmaceutical development. The company operates primarily in the United States, aiding clients in identifying potential drug candidates through advanced structural analysis techniques.
Investors in Vernal
Vernal has secured backing from 2 investors, including venture fund investors. Prominent investors backing the company include Orioninc and Potomac Equity Partners.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Potomac Equity Partners is engaged in private equity investments. | potomacequitypartners.com | Washington, D.C., United States | ||
Provider of AI, data analytics, application development and IT security services | 1993 | orioninc.com | Monmouth Junction, United States |
Investor details for Vernal
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Timeline of Vernal
2 dated milestones of Vernal across 7 years, from founding to its latest funding, stage changes and deals.
- Founded Vernal is founded.
- Exit Acquired by Orioninc.
Competitors of Vernal
Vernal has 3 listed competitors in our database, 3 of them funded. They include NTxBio, Nimble Therapeutics and Applied BioMath.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| ntxbio.com | 2016 | Santa Fe, United States | $74.76M | Provider of bio informatics platform to develops biologics and therapeutics | ||
| nimbletherapeutics.com | 2019 | Madison, United States | $10M | 24 | Combinatorial chemistry services for peptide-based drug discovery are provided. | |
| appliedbiomath.com | 2013 | Cambridge, United States | $2.32M | 61 | Systems biology and pharmacology modeling services to aid drug discovery and development |
Detailed competitors of Vernal
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Top companies in Life Sciences Platforms & Tools
3 companies that operate in the same segment as Vernal (Life Sciences Platforms & Tools) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Medidata is recognized as a leading provider of SaaS solutions for clinical research. | 1999 | New York, New York, United States | USD 41.5 M | |||
AI-based solutions for health management are provided. | 2015 | Dallas, Texas, United States | USD 2.8 B | 1,111 | ||
Real-world health data is provided for research and decisions. | 2012 | Menlo Park, California, United States | USD 259.16 M |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Vernal
Complete news archive for Vernal
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Vernal
Vernal was founded in 2010.
Vernal is headquartered in New York, United States. It is registered at New York, New York, United States.
Vernalis was founded in 2010 and is headquartered in New York, United States. Operations focus on the biotechnology sector, where a specialized platform for fragment and structure-based drug discovery is utilized. Services encompass early-stage research tools and methodologies to support pharmaceutical development. The company operates primarily in the United States, aiding clients in identifying potential drug candidates through advanced structural analysis techniques.
Vernal's top competitors include NTxBio, Nimble Therapeutics and Applied BioMath.
Vernal has 2 investors. Key investors include Orioninc, and Potomac Equity Partners.
Yes. Vernal was acquired by Orioninc in March 2017.